3-(2-(1,3-dioxolan-2-yl)ethyl)-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one - Names and Identifiers
Name | 3-[2-(1,3-Dioxolan-2-yl)ethyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one
|
Synonyms | 3-[2-(1,3-Dioxolan-2-yl)ethyl]-7,8-dimethoxy-1,3,4,5-tetrahy... 3-(2-(1,3-dioxolan-2-yl)ethyl)-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one 3-[2-(1,3-Dioxolan-2-yl)ethyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one 2H-3-Benzazepin-2-one, 3-[2-(1,3-dioxolan-2-yl)ethyl]-1,3,4,5-tetrahydro-7,8-dimethoxy- 2H-3-benzazepin-2-one, 3-[2-(1,3-dioxolan-2-yl)ethyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-
|
CAS | 866462-51-3
|
InChI | InChI=1/C17H23NO5/c1-20-14-9-12-3-5-18(6-4-17-22-7-8-23-17)16(19)11-13(12)10-15(14)21-2/h9-10,17H,3-8,11H2,1-2H3 |
3-(2-(1,3-dioxolan-2-yl)ethyl)-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one - Physico-chemical Properties
Molecular Formula | C17H23NO5
|
Molar Mass | 321.37 |
Density | 1.173 |
Boling Point | 505.966°C at 760 mmHg |
Flash Point | 259.799°C |
Vapor Presure | 0mmHg at 25°C |
Storage Condition | 2-8°C |
Refractive Index | 1.529 |
3-(2-(1,3-dioxolan-2-yl)ethyl)-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one - Introduction
The compound 3-[2-(1,3-Dioxolan-2-yl)ethyl]-7,8-dimethoxy-1,3,4-, (abbreviated as DBE) is an organic compound. The following describes its nature, use, preparation and safety information:
Nature:
-Appearance: DBE is a white solid.
-Melting point: The melting point of DBE is usually between 100-105 degrees Celsius.
-Solubility: DBE has low solubility in water and good solubility in common organic solvents.
Use:
-Pharmaceutical research: DBE is commonly used as an organic synthetic intermediate in pharmaceutical research and can be used to synthesize various biologically active compounds.
-Chemical synthesis: DBE can be used as a medium or ligand to participate in a variety of reactions in organic synthesis, such as reduction reactions, carbonylation reactions, etc.
Preparation Method:
There are many preparation methods for DBE, and the common methods include the following steps:
1.1,3-dioxolane reacts with bromoethane to generate 2-(1,3-dioxolan-2-yl) ethyl bromide.
2. react 2-(1,3-dioxolan-2-yl) ethyl bromide with benzazepine to generate DBE.
3. Finally, through appropriate chemical treatment steps, high purity DBE can be obtained.
Safety Information:
Due to the nature and use of the compound, it is necessary to operate in a professional laboratory environment, follow relevant safety procedures, and wear appropriate protective equipment. DBE may have certain effects on human health under certain conditions, such as skin irritation, eye irritation, etc., so contact with skin and eyes should be avoided. In addition, DBE also has a certain degree of combustion, in the process of operation should avoid contact with open flame or high temperature. DBE should be handled in accordance with safe operating procedures and stored and disposed of in accordance with relevant national regulations and standards.
Last Update:2024-04-09 21:04:16